Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 29, 2025 07:13 ET | Source: The Insight Partners

Tympanostomy Products Market to Reach $121.88 Million by 2031 Driven by Rising Ear Infections and Technological Advancements

US & Canada, Jan. 29, 2025 (GLOBE NEWSWIRE) -- According to a comprehensive report from The Insight Partners, “Tympanostomy Products Market Size and Forecast (2021 - 2031), Global and Regional...
December 04, 2019 11:43 ET | Source: Tusker Medical

Breakthrough In-Office Ear Tube Solution From Tusker Medical Receives FDA Approval

Tula System Offers ENTs, Patients and Parents an Option Without the Operating Room Menlo Park, CA, Dec. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tusker® Medical today announced United...
October 07, 2016 08:00 ET | Source: Otonomy, Inc.

Otonomy Holds Investor and Analyst Day and Provides Corporate Update

SAN DIEGO, Oct. 07, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and...
March 18, 2016 07:30 ET | Source: Otonomy, Inc.

Otonomy Announces Publication of OTIPRIO™ Phase 3 Clinical Trial Results in JAMA Otolaryngology

SAN DIEGO, March 18, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
December 11, 2015 07:30 ET | Source: Otonomy, Inc.

Otonomy Announces FDA Approval of OTIPRIO(TM) for the Treatment of Pediatric Patients Undergoing Tympanostomy Tube Placement Surgery

U.S. Commercial Launch Expected in the First Quarter of 2016 Webcast and Conference Call at 8:30 a.m. EST Today SAN DIEGO, Dec. 11, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a...
November 03, 2015 07:30 ET | Source: Otonomy, Inc.

Otonomy Initiates Open-Label Clinical Trial for OTIPRIO(TM) in Pediatric Patients With History of Otitis Media Requiring Tympanostomy Tubes

SAN DIEGO, Nov. 3, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
September 30, 2015 07:30 ET | Source: Otonomy, Inc.

Otonomy to Host Investor and Analyst Day on October 7, 2015

SAN DIEGO, Sept. 30, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC) will host an Investor and Analyst Day on Wednesday, October 7, 2015, from 8:30 a.m. to 11:30 a.m. EDT (5:30 a.m. to 8:30 a.m....
September 24, 2015 07:30 ET | Source: Otonomy, Inc.

Otonomy to Present Results for AuriPro(TM) Phase 3 and OTO-104 Phase 2b Clinical Trials at 2015 AAO-HNSF Annual Meeting

SAN DIEGO, Sept. 24, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
September 09, 2015 07:30 ET | Source: Otonomy, Inc.

Otonomy Announces Successful End-of-Phase 2 Meeting With the FDA for OTO-104 in Meniere's Disease

SAN DIEGO, Sept. 9, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
September 01, 2015 07:30 ET | Source: Otonomy, Inc.

Otonomy Appoints Ted Schroeder to Board of Directors

SAN DIEGO, Sept. 1, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...

Next Page keyboard_arrow_right